By Tiffany Hu ( June 3, 2019, 4:57 PM EDT) -- The U.S. Supreme Court on Monday declined to consider a challenge by Allergan Inc. and the St. Regis Mohawk Tribe to the "blocking patent" doctrine, leaving in place a Federal Circuit ruling that invalidated their patents covering the dry-eye medication Restasis....
Law360 is on it, so you are, too.
A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.
A Law360 subscription includes features such as
- Daily newsletters
- Expert analysis
- Mobile app
- Advanced search
- Judge information
- Real-time alerts
- 450K+ searchable archived articles
And more!
Experience Law360 today with a free 7-day trial.